Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion

Food Chemistry

Volumn 125, Issue 2, 2011, Pages 561-569

  Jimsheena, V K ^a   Gowda, Lalitha R ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Antihypertensive peptide; Arachis hypogaea; Hypertension; Molecular docking; Peanut

Indexed keywords

ANTIHYPERTENSIVE PEPTIDE; ARACHIS HYPOGAEA; HYPERTENSION; MOLECULAR DOCKING; PEANUT;

BLOOD PRESSURE; DOCKING; ENZYME INHIBITION; ENZYMES; MOLECULAR MODELING;

PEPTIDES;

ANTIHYPERTENSIVE AGENT; ARACHIN PROTEIN; ASPARAGINYLALANYLGLUTAMINYLARGINYLPROLINE; ASPARAGINYLLEUCYLALANYLGLYCINE; CHYMOTRYPSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMINYLARGINYLPROLINE; ISOLEUCYLGLUTAMYLTHREONYLTRYPTOPHYLASPARAGINYLPROLYLASPARAGINYLASPARAGINYLGLUTAMINE; ISOLEUCYLLYSYLPROLINE; LEUCYLARGINYLTRYPTOPHAN; LISINOPRIL; PANCREATIN; PENTAPEPTIDE; PEPSIN A; PHENYLALANYLTRYPTOPHAN; TRYPSIN; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD PRESSURE; CATALYSIS; CONTROLLED STUDY; DIGESTION; DRUG BINDING; DRUG INHIBITION; DRUG POTENCY; DRUG SYNTHESIS; IC 50; IN VITRO STUDY; INGESTION; MOLECULAR DOCKING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PURIFICATION; PROTEIN SECRETION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STOMACH JUICE;

ARACHIS HYPOGAEA;

EID: 78049435251     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2010.09.048     Document Type: Article

References (30)

1. Bidlingmeyer B.A., Cohen S.A., Tarvin T.L. Rapid analysis of amino acids using pre-column derivatization. Journal of Chromatography 1984, 336(1):93-104.
2. Bougatef A., Nedjar-Arroume N., Manni L., Ravallec R., Barkia A., Guillochon D., et al. Purification and identification of novel antioxidant peptides from enzymatic hydrolysates of sardinelle (Sardinella aurita) by-products proteins. Food Chemistry 2010, 118(3):559-565.
3. Burks A.W., Cockrell G., Connaughton C., Karpas A., Helm R.M. Epitope specific city of the major peanut allergen, Ara h II. Journal of Allergy and Clinical Immunoogy 1995, 95:607-611.
4. Chabance B., Marteau P., Rambaud J.C., Migliore-Samour D., Boynard M., Perrotin P., et al. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 1998, 80(2):155-165.
5. Cheung I.W., Nakayama S., Hsu M.N., Samaranayaka A.G., Li-Chan E.C. Angiotensin-I converting enzyme inhibitory activity of hydrolysates from oat (Avena sativa) proteins by in silico and in vitro analyses. Journal of Agricultural and Food Chemistry 2009, 57(19):9234-9242.
6. Coppey L.J., Davidson E.P., Rinehart T.W., Gellett J.S., Oltman C.L., Lund D.D., et al. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2006, 55(2):341-348.
7. Dziuba J., Minkiewicz P., Nalecz D., Iwaniak A. Database of biologically active peptide sequences. Nahrung 1999, 43(3):190-195.
8. Erdmann K., Cheung B.W.Y., Schröder H. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. Journal of Nutritional Biochemistry 2008, 19(10):643-654.
9. Ferreira S.H. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. British Journal of Pharmacology and Chemotherapy 1965, 24:163-169.
10. Fujita H., Yoshikawa M. LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 1999, 44(1-2):123-127.
11. Gouda M.K.G., Gowda L.R., Rao A.G., Prakash V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). Journal of Agricultural and Food Chemistry 2006, 54(13):4568-4573.
12. Guang C., Phillips R.D. Purification, activity and sequence of angiotensin I converting enzyme inhibitory peptide from alcalase hydrolysate of peanut flour. Journal of Agricultural and Food Chemistry 2009, 57(21):10102-10106.
13. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Speizer F.E., et al. Dietary protein and risk of ischemic heart disease in women. American Journal of Clinical Nutrition 1999, 70(2):221-227.
14. Jimsheena V.K., Gowda L.R. Colorimetric, high-throughput assay for screening Angiotensin I-converting enzyme inhibitors. Analytical Chemistry 2009, 81(22):9388-9394.
15. Jimsheena, V. K., & Gowda, L. R. (2010). Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: Structure-activity relationship. Peptides. doi:10.1016/j.peptides.2010.02.022.
16. Kritchevsky D., Tepper S.A., Czarnecki S.K., Klurfeld D.M. Atherogenicity of animal and vegetable protein. Influence of the lysine to arginine ratio. Atherosclerosis 1982, 41(2-3):429-431.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
18. Lopez A.D., Murray C.C. The global burden of disease, 1990-2020. Nature Medicine 1998, 4(11):1241-1243.
19. Masuda O., Nakamura Y., Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. Journal of Nutrition 1996, 126(12):3063-3068.
20. Meisel, H., Walsh, D. J., Murray, B., & Fitzgerald, R. J. (2006). In ACE Inhibitory peptides (Nutraceutical Proteins and Peptides in Health and Disease. 2006 ed. Vol. 4), Taylor & Francis Group. (pp. 269-315).
21. Natesh R., Schwager S.L., Sturrock E.D., Acharya K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421(6922):551-554.
22. Pina A.S., Roque A.C. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. Journal of Molecular Recognition 2009, 22(2):162-168.
23. Pripp, A. H. (2008). Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food and Nutrition Research, 52. doi:10.3402/fnr.v52/0.1641.
24. Roberts P.R., Burney J.D., Black K.W., Zaloga G.P. Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion 1999, 60(4):332-337.
25. Suetsuna K., Nakano T. Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). Journal of Nutritional Biochemistry 2000, 11(9):450-454.
26. van der Zander K., Jakel M., Bianco V., Koning M.M.G. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. Journal of Human Hypertension 2008, 22(11):804-806.
27. Vermeirssen V., Van Camp J., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 2004, 92(3):357-366.
28. Wu J., Aluko R.E., Nakai S. Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di- and tripeptides. Journal of Agricultural and Food Chemistry 2006, 54(3):732-738.
29. Yamaguchi N., Kawaguchi K., Yamamoto N. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. European Journal of Pharmacology 2009, 620(1-3):71-77.
30. Yu J., Ahmedna M., Goktepe I. Peanut protein concentrate: Production and functional properties as affected by processing. Food Chemistry 2007, 103(1):121-129.